Showing results (31-40 of 10,181) with videos related to

Sort By:
Pageof 1,019
Molecular Pharmacology|April 1, 1990
Non-steady state kinetic analysis of the regulation of adenylate cyclase by GTP-binding proteinsJ D Bell, R L Biltonen, L L Brunton
Molecular Pharmacology|April 1, 1990
2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosineR Masood, G S Ahluwalia, D A Cooney, et al.
Molecular Pharmacology|February 16, 2011
Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astrogliaSophie J Bradley, Christopher J Langmead, Jeannette M Watson, et al.
Molecular Pharmacology|January 12, 2011
The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidenceXinliang Mao, Tingjun Hou, Biyin Cao, et al.
Molecular Pharmacology|December 15, 2010
The large isoforms of A-kinase anchoring protein 18 mediate the phosphorylation of inhibitor-1 by protein kinase A and the inhibition of protein phosphatase 1 activityArpita Singh, John M Redden, Michael S Kapiloff, et al.
Molecular Pharmacology|December 22, 2010
Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3Pablo Martinez-Becerra, Oscar Briz, Marta R Romero, et al.
Molecular Pharmacology|September 10, 2010
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activityPingwei Zhao, Haleli Sharir, Ankur Kapur, et al.
Molecular Pharmacology|July 9, 2010
Elimination of a hydroxyl group in FTY720 dramatically improves the phosphorylation rateEve Jary, Thomas Bee, Scott R Walker, et al.
Molecular Pharmacology|December 17, 2010
Nitric oxide stimulates NCX1 and NCX2 but inhibits NCX3 isoform by three distinct molecular determinantsAgnese Secondo, Pasquale Molinaro, Anna Pannaccione, et al.
Molecular Pharmacology|December 17, 2010
Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotectiveFilippo Caraci, Gemma Molinaro, Giuseppe Battaglia, et al.
Pageof 1,019